(object) array( 'id' => '1460609', 'url' => 'SR/confidentiality_regarding_trial_participants', 'image' => '', 'title' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'tags' => array ( 0 => 'poverljivost podataka učesnika u kliničkom ispitivanju', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'source_id' => 30883, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705083507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na poštovanje poverljivosti podataka učesnika u kliničkom ispitivanju uključujući njihov identitet i sve lične medicinskwe informacije. Odobrenje za korišćenje dobijenih podataka radi verifikacije samih podataka mora unapred biti dobijeno od učesnika ispitivanja kao i uverenje da poverljivost mora biti zagarantovana.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964695805952, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'confidentiality regarding trial participants', 'Definition' => 'Refers to maintaining the confidentiality of trial participants including their personal identity and all personal medical information. The trial participants\' consent to the use of records for data verification purposes should be obtained prior to the trial and assurance must be given that confidentiality will be maintained.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'confidentiality_regarding_trial_participants', )

(object) array( 'id' => '1467658', 'url' => 'SR/Merck', 'image' => '', 'title' => 'Merck', 'tags' => array ( 0 => 'Merck', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Merck', 'source_id' => 31152, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Američka farmaceutska kompanija', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845764, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Merck', 'Definition' => 'a US pharmaceutical company', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Merck', )

(object) array( 'id' => '1461003', 'url' => 'SR/data_safety_and_monitoring_board_(dsmb)', 'image' => '', 'title' => 'Odbor za bezbednost podataka i monitoring', 'tags' => array ( 0 => 'Odbor za bezbednost podataka i monitoring', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Odbor za bezbednost podataka i monitoring', 'source_id' => 30887, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152003', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Nezavisni odbor koji se sastoji od predstavnika udruženja i stručnjaka za klinička ispitivanja koji vrše pregled podataka u toku samog kliničkog ispitivanja radi sigurnosti da učestnici nisu izloženi nepotrebnom riziku. ovaj Odbor(DSMB)može predložiti okončanje ispitivanja ukoliko postoji sumnja u bezbedenost iii ukoliko su ciljevi ispitivanja postignuti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907777, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'data safety and monitoring board (dsmb)', 'Definition' => 'An independent committee, composed of community representatives and clinical research experts, that reviews data while a clinical trial is in progress to ensure that participants are not exposed to undue risk. A DSMB may recommend that a trial be stopped if there are safety concerns or if the trial objectives have been achieved.', 'Synonym' => 'DSMB_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'data_safety_and_monitoring_board_(dsmb)', )

(object) array( 'id' => '1461310', 'url' => 'SR/personal_file_access_policy', 'image' => '', 'title' => 'Politika pristupa ličnim fajlovima', 'tags' => array ( 0 => 'Politika pristupa ličnim fajlovima', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'Politika pristupa ličnim fajlovima', 'source_id' => 40104, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705223509', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Politika koja dozvoljava sadašnjim i ranijim zaposlenima pristup svojim fajlovima, pod uslovom da unpared o tome obaveste menadžera za ljudske resurse.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967782813699, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'personal file access policy', 'Definition' => 'A policy allowing current and prior employees access to their own files, provided they let HR know in advance.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'personal_file_access_policy', )

(object) array( 'id' => '1467622', 'url' => 'SR/Food_and_Drug_Administration', 'image' => '', 'title' => 'Administraija za hranu i lekove', 'tags' => array ( 0 => 'Administraija za hranu i lekove', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Administraija za hranu i lekove', 'source_id' => 30899, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110709203524', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Deo američkog Zavoda za Zdravlje i Zdravstvene Usluge odgovoran za obezbeđivanje bezbednosti i efikasnosti svih lekova, bioloških preparata, vakcina i medicinskih sredstava, uključujući one koji se koriste u dijagnostici, lečenju i prevenciji HIV-a, AIDS-a ili oportunističkih infekcija uzrokovanih AIDS-om. Administracija za hranu i lekove (FDA)takođe sarađuje sa industrijom banaka krvi u cilju obezbeđivanja zaliha krvi naciji. Internet adresa', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999168790529, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Food and Drug Administration', 'Definition' => 'The U.S. Department of Health and Human Services agency responsible for ensuring the safety and effectiveness of all drugs, biologics, vaccines, and medical devices, including those used in the diagnosis, treatment, and prevention of HIV infection, AIDS, and AIDS-related opportunistic infections. The FDA also works with the blood banking industry to safeguard the nation\'s blood supply. Internet address', 'Synonym' => 'FDA_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Food_and_Drug_Administration', )

(object) array( 'id' => '1461320', 'url' => 'SR/market_positioning', 'image' => '', 'title' => 'pozocioniranje na tržištu', 'tags' => array ( 0 => 'pozocioniranje na tržištu', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'pozocioniranje na tržištu', 'source_id' => 57180, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225508', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Pokušaj izdvajanja proizvoda od drugih konkurentskih sličnim njemu, stvarajući utisak o jedinstvenosti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967784910848, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'market positioning', 'Definition' => 'An attempt to distinguish a product from its similar competitors by creating a perception of uniqueness.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/18', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/18', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'market_positioning', )

(object) array( 'id' => '1460561', 'url' => 'SR/thrombolytic_therapy', 'image' => '', 'title' => 'trombolitička terapija', 'tags' => array ( 0 => 'trombolitička terapija', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'trombolitička terapija', 'source_id' => 1047729, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20110705074502', 'part_of_speech' => 'other', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Upotreba lekova u cilju razbijanja ili rastvaranja krvnih ugrušaka, koji su glavni uzrok i srčanog i moždanog udara.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964533276677, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'thrombolytic therapy', 'Definition' => 'Use of drugs to break up or dissolve blood clots, which are the main cause of both heart attacks and stroke.', 'Part of Speech' => 'other', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Drugs', 'Creation User' => 'CCTRADUCTION', 'Creation Date' => '2011/4/13', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'thrombolytic_therapy', )

(object) array( 'id' => '1460603', 'url' => 'SR/meta-analysis_₁', 'image' => '', 'title' => 'meta-analiza', 'tags' => array ( 0 => 'meta-analiza', 1 => 'Education', 2 => 'Teaching', 3 => 'Teachnology', 4 => '', ), 'term' => 'meta-analiza', 'source_id' => 712334, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Education', ), 'category' => array ( 0 => 'Teaching', ), 'company' => array ( 0 => 'Teachnology', ), 'lastedit' => '20110705082507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Statistička procedura za inegraciju rezultata različitih studija.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964694757377, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'meta-analysis', 'Company' => 'Teachnology', 'Definition' => 'Statistical procedure for integrating the results of different studies.', 'Domain' => 'Documentation', 'Industry' => 'Education', 'Part of Speech' => 'noun', 'Product Category' => 'Teaching', 'Usage Status' => 'New', 'Creation User' => 'katesd', 'Creation Date' => '2011/2/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'meta-analysis_₁', )

(object) array( 'id' => '1461048', 'url' => 'SR/phase_ii_trials', 'image' => '', 'title' => 'Druga faza ispitivanja', 'tags' => array ( 0 => 'Druga faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Druga faza ispitivanja', 'source_id' => 30917, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Kontrolisane kliničke studije koje se sprovode sa ciljem procene efikasnosti leka za određenu indikaciju ili indikacije kod pacijenta sa oboljenjem ili stanjem koje se ispituje kao i determinacije uobičajenih kratkotrajnih neželjenih dejstava i rizka.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247811, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase ii trials', 'Definition' => 'Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_ii_trials', )

(object) array( 'id' => '1460562', 'url' => 'SR/pharmaceuticals', 'image' => '', 'title' => 'lekovi', 'tags' => array ( 0 => 'lekovi', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'lekovi', 'source_id' => 114398, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20110705074504', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Hemijska supstanca koja se koristi u medicinske svrhe, uključujući dijagnostiku, lečenje ili prevenciju bolesti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964534325248, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'pharmaceuticals', 'Definition' => 'Chemical substance for medical purposes, including diagnosis, treatment and prevention of disease.', 'Synonym' => 'medicine_₀', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Drugs', 'Industry' => 'Pharmaceutical', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/7/20', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'pharmaceuticals', )